Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

108.95
-0.9000-0.82%
Volume:2.37M
Turnover:258.38M
Market Cap:135.53B
PE:23.03
High:110.15
Open:109.12
Low:108.16
Close:109.85
Loading ...

Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
14 Jun

Jefferies sees Akero, Scholar Rock as ‘promising’ takeover targets

TIPRANKS
·
13 Jun

Gilead Sciences Inc. Stock Climbs 2.5%, Outperforms Competitors

Dow Jones
·
13 Jun

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2025-06-12

Reuters
·
13 Jun

Bernstein Sticks to Their Buy Rating for Gilead Sciences (GILD)

TIPRANKS
·
12 Jun

Gilead Sciences' Lenacapavir Provides 'Solid' Switching Opportunities for Current PrEP Users, RBC Says

MT Newswires Live
·
12 Jun

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA) and Gilead Sciences (GILD)

TIPRANKS
·
11 Jun

Gilead Sciences: Buy Rating Affirmed Amid Strategic Positioning and Robust HIV Pipeline

TIPRANKS
·
11 Jun

Gilead : RBC Raises Target Price to $95 From $92

THOMSON REUTERS
·
11 Jun

RBC Capital Raises Price Target on Gilead Sciences to $95 From $92, Keeps Sector Perform Rating

MT Newswires Live
·
11 Jun

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
11 Jun

Oppenheimer ‘not sounding the alarm just yet’ on Gilead after clinical hold

TIPRANKS
·
10 Jun

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-06-10

Reuters
·
10 Jun

Citi sees Gilead clinical holds as only ‘minor setback’

TIPRANKS
·
10 Jun

Gilead weekly oral hold should not affect lenacapavir PDUFA, says RBC Capital

TIPRANKS
·
10 Jun

Gilead down 2% to $111.14 after FDA placed hold on some HIV trials

TIPRANKS
·
10 Jun

Gilead Sciences Shares Down 1.9% After U.S. FDA Puts Two Trials Testing Co's Hiv Pill Combination on Clinical Hold

THOMSON REUTERS
·
10 Jun

US FDA places clinical hold on 2 Gilead trials of weekly HIV pill combination

Reuters
·
10 Jun

Gilead: Hold Due to Identification of Safety Signal of Decreases in Cd4+T-Cell & Absolute Lymphocyte Counts in Subset of Participants Getting Combo

THOMSON REUTERS
·
10 Jun

Gilead - FDA Placed a Clinical Hold on Gilead’s Hiv Treatment Trials of Gs-1720 and/or Gs-4182

THOMSON REUTERS
·
10 Jun